Search

Author/Creator Tan, W.

1. 126P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) in patients (pts) with checkpoint inhibitor (CPI)-experienced advanced non-small cell lung cancer (NSCLC). (December 2022)

Authors:
Frentzas, S.; Meniawy, T.; Kao, S.C-H.; Coward, J.; Clay, T.D.; Singhal, N.; Black, A.; Xu, W.; Kumar, R.; Lee, Y.; Lee, G-W.; Liao, W.; Zhong, D.; Shiah, H-S.; Chen, Y-M.; Gao, R.; Wang, R.; Zheng, H.; Tan, W.; Cho, E.K.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 148P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC). (December 2022)

Authors:
Zhang, J.; Hussein, M.; Kao, S.C-H.; Clay, T.D.; Singhal, N.; Kim, H.R.; Cho, E.K.; Shim, B.; Lee, Y.; Lee, G-W.; Zhao, J.; Yu, Y.; Sun, M.; Lin, C-B.; Yang, T-Y.; Chang, G-C.; Zheng, H.; Tan, W.; Spigel, D.R.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 2315 A phase Ib study of the FGFR/VEGFR inhibitor dovitinib (D) combined with gemcitabine (G) and Capecitabine (C) in advanced pancreatic cancer patients. (September 2015)

Authors:
Ma, W.W.; Fetterly, G.; LeVea, C.; Zhao, Y.; Dy, G.K.; Iyer, R.; Tan, W.; Brady, W.; Whitworth, A.; Adjei, A.A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S438
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 2523 Feasibility analysis of pathology and genetic yield from a prospective trial of tissue biopsies in metastatic castrate resistant prostate cancer. (September 2015)

Authors:
Jimenez, R.; Sicotte, H.; Barman, P.; Sinnwell, J.; Eiken, P.; Atwell, T.; McMenomy, B.; Tan, W.; Wu, K.; Bryce, A.; Ho, T.; Pitot, H.; Quevedo, J.F.; Costello, B.; Dronca, R.; Moynihan, T.; Wang, L.; Qin, R.; Carlson, R.; Kohli, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S482
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 2573 Impact of biopsy of metastases on circulating tumor cell (CTC) counts in castrate resistant prostate cancer (CRPC). (September 2015)

Authors:
Kohli, M.; Tan, W.; Eiken, P.; McMenomy, B.; Atwell, T.; Carlson, R.; Campion, M.; Wang, L.; Costello, B.; Pitot, H.; Quevedo, F.; Ho, T.; Bryce, A.; Qin, R.; Paz-Fumagalli, R.; Moynihan, T.; Dronca, R.; Liu, M.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S502
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗